Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
Franceschi E, Cavallo G, Scopece L, Paioli A, Pession A, Magrini E, Conforti R, Palmerini E, Bartolini S, Rimondini S, et al. Br J Cancer. 2004 Sep 13; 91(6):1038-44.